GGrantIndex
Sort

8,912 grants matching sars cov 2

Core--SARS Coronavirus Clone and Reagent

$196,600
Ralph S Baric · Univ Of North Carolina Chapel Hill · P01 · FY2008 · AI

Enhanced infectivity of SARS-CoV-2 in Particulate Matter exposed Sinonasal Epithelial Cells

$196,500
Murugappan Ramanathan · Johns Hopkins University · R01 · FY2020 · AI

RAPID: What is the role of extracellular vimentin in SARS2 host cell entry?

$196,457
Alison E Patteson · Syracuse University · · FY2020 · BIO

No power, at home COVID diagnostic with tactile readout

$196,445
Charles B. Dhong · University Of Delaware · R21 · FY2024 · EY

Novel Hamster Models of Chikungunya Viral Arthritis

$196,407
Tian Wang · University Of Texas Med Br Galveston · R21 · FY2025 · AI

The Unilateral Mosaic (UMos): Novel tools to compartmentalize pathology and trace cellular interactions in mouse models of human disease

$196,250
David W Gludish · Cornell University · R21 · FY2025 · OD

Mentorship in patient-oriented research to optimize community-based HIV prevention for adults at high-risk of HIV at alcohol drinking venues in East Africa

$196,250
Gabriel Chamie · University Of California, San Francisco · K24 · FY2023 · AA

Quantifying the spectrum and dynamics of B-cell binding avidity in response to influenza

$196,250
Steven Carl George · University Of California At Davis · R21 · FY2021 · AI

Improving the Immune Response to Nanoparticle-Based SARS-CoV-2 Vaccines

$196,250
Szu-Wen Wang · University Of California-Irvine · R21 · FY2024 · AI

Unravelling the mechanisms of virus host species jump

$196,250
Masmudur Mohammed Rahman · Arizona State University-Tempe Campus · R21 · FY2022 · AI

ACE2-independent alternative receptors for SARS-CoV-2 at the oral mucosa

$196,250
Theresa L Chang · Rutgers Biomedical And Health Sciences · R21 · FY2025 · DE

Identification of olfactory mucosa protein fingerprints in COVID-19

$196,250
Qizhi Gong · University Of California At Davis · R21 · FY2022 · AI

Broad-based spike protein stalk-based vaccine platform for SARS-CoV-2 and other coronaviruses

$196,250
Gary R Whittaker · Cornell University · R21 · FY2021 · AI

Mentorship in patient-oriented research to optimize community-based HIV prevention for adults at high-risk of HIV at alcohol drinking venues in East Africa

$196,250
Gabriel Chamie · University Of California, San Francisco · K24 · FY2025 · AA

Mentorship in patient-oriented research to optimize community-based HIV prevention for adults at high-risk of HIV at alcohol drinking venues in East Africa

$196,250
Gabriel Chamie · University Of California, San Francisco · K24 · FY2024 · AA

Immune phenotyping of responses to influenza virus vaccination and infection

$196,104
Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2024 · AI

Intracellular functions and mechanisms of alphavirus ion channel 6K

$196,044
Joyce Jose · Pennsylvania State University, The · R21 · FY2024 · AI

Cryo-ET Structural Biology of Herpesvirus Infection and Morphogenesis In Situ.

$196,016
Wah Chiu · Stanford University · R21 · FY2021 · AI

Rapid detection of infectious viral particles by cluster induced exhaustive reaction

$196,012
Jun Wang · State University New York Stony Brook · R21 · FY2021 · AI

Epidemiologic and Translational Investigation of Long-Term Kidney Outcomes After COVID-19

$195,960
Steven Menez · Johns Hopkins University · K23 · FY2025 · DK

Live-cell imaging of SARS-CoV-2 replication organelle formation and RNA synthesis

$195,800
Zandrea Ambrose · University Of Pittsburgh At Pittsburgh · R21 · FY2023 · AI

Vaccine-induced SARS-CoV-2-specific T cell responses in patients with X-linked Agammaglobulinemia

$195,770
Kristina Abel · Univ Of North Carolina Chapel Hill · R21 · FY2024 · AI

Assessing the impact of COVID-19 interventions on human mobility and SARS-CoV-2 transmission dynamics in the United States

$195,625
Sean Michael Moore · University Of Notre Dame · R21 · FY2022 · AI

Novel treatment for respiratory distress due to SARS-CoV2 infection

$195,625
Kathy K Griendling · Emory University · R21 · FY2022 · AI

Leveraging iPSC technology to understand neuro-immune responses to SARS-CoV-2 variants

$195,625
Zhexing Wen · Emory University · R21 · FY2025 · NS